FDA NDC Directory · JSON-LD · Markdown

INZIRQO

NDC 70954-522 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Generic namehydrochlorothiazide
Labeler / ManufacturerANI Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA219141
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsHYDROCHLOROTHIAZIDE (10 mg/mL)
Marketing started20250130
Package count1

External sources

Source: openFDA. Public-domain (CC0).